🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Several professionals said the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, prosecution or prison.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Research also found groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or injecting at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.

Product Information and Costs

Within these communities, posts display dark colored packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious health risks”.